Angelina Jolie's faulty gene: Newspaper coverage of a celebrity's preventive bilateral mastectomy in Canada, the United States, and the United Kingdom

Genetics in Medicine

Volumn 16, Issue 7, 2014, Pages 522-528

  Kamenova, Kalina ^a   Reshef, Amir ^a   Caulfield, Timothy ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

BRCA genetic testing; Content analysis; Hereditary breast and ovarian cancer; Newspapers; Preventive mastectomy

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; BRCA1 PROTEIN, HUMAN; BRCA2 PROTEIN, HUMAN;

ARTICLE; BREAST RECONSTRUCTION; CANADA; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CONTENT ANALYSIS; ESTHETIC SURGERY; FAULTY GENE; FEMALE; GENE; GENETIC RISK; GENETIC SCREENING; HEALTH CARE; HEREDITARY BREAST AND OVARIAN CANCER SYNDROME; HUMAN; MASTECTOMY; MEDICAL DECISION MAKING; MEDICAL INFORMATION; PREVENTIVE MEDICINE; PUBLICATION; RISK ASSESSMENT; RISK FACTOR; TUMOR GENE; UNITED KINGDOM; UNITED STATES; BREAST NEOPLASMS; ELECTIVE SURGERY; GENETIC PREDISPOSITION; GENETICS; INFORMATION DISSEMINATION; MUTATION; OVARIAN NEOPLASMS; PRIMARY PREVENTION; PUBLIC FIGURE; PUBLIC OPINION; QUESTIONNAIRE; UTILIZATION;

BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; CANADA; ELECTIVE SURGICAL PROCEDURES; FAMOUS PERSONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GREAT BRITAIN; HUMANS; INFORMATION DISSEMINATION; MASTECTOMY; MUTATION; NEWSPAPERS; OVARIAN NEOPLASMS; PRIMARY PREVENTION; PUBLIC OPINION; QUESTIONNAIRES; RISK ASSESSMENT; UNITED STATES;

EID: 84903792582     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2013.199     Document Type: Article

References (40)

1. Jolie A. My Medical Choice. New York Times. 4 May 2013:A25.
2. National Cancer Institute at the National Institutes of Health (NCI). RCA1 and BRCA2: cancer risk and genetic testing. http://www.cancer.gov/ cancertopics/factsheet/Risk/BRCA.
3. Gold ER, Carbone J. Myriad genetics: in the eye of the policy storm. Genet Med 2010;12(suppl):S39-S70.
4. Adair A, Hyde-Lay R, Einsiedel E, Caulfield T. Technology assessment and resource allocation for predictive genetic testing: a study of the perspectives of Canadian genetic health care providers. BMC Med Ethics 2009;10:6.
5. Williams-Jones B. History of a gene patent: tracing the development and application of commercial BRCA testing. Health Law J 2002;10:123-146.
6. Angell M. Science on Trial: The Clash of Medical Evidence and the Law in the Breast Implant Case. WW Norton: New York, 1998.
7. Ransohoff DF, Ransohoff RM. Sensationalism in the media: when scientists and journalists may be complicit collaborators. Eff Clin Pract 2001;4:185-188.
8. Holtzman NA Are genetic tests adequately regulated? Science 1999 286 409
9. Bubela TM, Caulfield TA. Do the print media "hype" genetic research? A comparison of newspaper stories and peer-reviewed research papers. CMAJ 2004;170:1399-1407.
10. Caulfield T. Biotechnology and the popular press: hype and the selling of science. Trends Biotechnol 2004;22:337-339.
11. Association for Molecular Pathology v Myriad Genetics 569 US 12-398 (2013).
12. Swami V, Taylor R, Carvalho C. Acceptance of cosmetic surgery and celebrity worship: evidence of associations among female undergraduates. Pers Individ Dif 2009;47: 869-872.
13. Cram P, Fendrick AM, Inadomi J, Cowen ME, Carpenter D, Vijan S. The impact of a celebrity promotional campaign on the use of colon cancer screening: the Katie Couric effect. Arch Intern Med 2003;163:1601-1605.
14. Mackenzie R, Chapman S, Johnson N, McGeechan K, Holding S. The newsworthiness of cancer in Australian television news. Med J Aust 2008;189:155-158.
15. Chapman S, McLeod K, Wakefield M, Holding S. Impact of news of celebrity illness on breast cancer screening: Kylie Minogue's breast cancer diagnosis. Med J Aust 2005;183:247-250.
16. Nattinger AB, Hoffmann RG, Howell-Pelz A, Goodwin JS. Effect of Nancy Reagan's mastectomy on choice of surgery for breast cancer by US women. JAMA 1998;279:762-766.
17. Brown ML, Potosky AL. The presidential effect: the public health response to media coverage about Ronald Reagan's colon cancer episode. Public Opin Q 1990;54:317-329.
18. Garrett JM, Bird SJ. Ethical issues in communicating science. Sci Eng Ethics 2000;6:435-442.
19. Friedman SM, Dunwoody S, Rogers CL (eds). Communicating Uncertainty: Media Coverage of New and Controversial Science. Lawrence Erlbaum Associates: Mahwah, NJ, 1999.
20. Miller D, Kitzinger J, Williams K. The Circuit of Mass Communication: Media Strategies, Representation and Audience Reception in the AIDS Crisis. Sage Publications: London, 1998.
21. Entman R. Framing: toward a clarification of a fractured paradigm. J Commun 1993;43:51-58.
22. Scheufele D. Framing as a theory of media effects. J Commun 1999;49: 103-122.
23. Mazur A. Media coverage and public opinion on scientific controversies. J Commun 1981;31:106-115.
24. Nisbet M, Brossard D, Kroepsch A. Framing science: the stem cell controversy in an age of press/politics. IJPP 2003;8:36-70.
25. Caulfield T, Bubela T, Murdoch CJ. Myriad and the mass media: the covering of a gene patent controversy. Genet Med 2007;9:850-855.
26. McCombs ME, Shaw DL. The agenda-setting function of mass media. Public Opin Q 1972;36:176-187.
27. Abelson J. Understanding the role of contextual influences on local healthcare decision making: case study results from Ontario, Canada. Soc Sci Med 2001;53:777-793.
28. Alliance for Audited Media, 2013 http://www.auditedmedia.com/news/ research-and-data/top-25-us-newspapers-for-march-2013.aspxAccessed30July2013.
29. The Audit Bureau of Circulations, 2013. http://www.abc.org.uk/ Certificates-Reports/Our-Reports/Accessed30July2013.
30. Dahlgren P, Sparks C. Journalism and Popular Culture. Sage Publications: London, 1992.
31. Lehman-Wilzig S, Seletzky M. Elite and popular newspaper publication of press releases: differential success factors? Public Relat J 2012;6:1-25.
32. Matthes J, Kohring M. The content analysis of media frames: towards improving reliability and vallidity. J Commun 2000;58:258-279.
33. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174.
34. Leyngold MM, Stutman RL, Khiabani KT, et al. Contributing variables to post mastectomy tissue expander infection. Breast J 2012;18:351-356.
35. Harcourt DM, Rumsey NJ, Ambler NR, et al. The psychological effect of mastectomy with or without breast reconstruction: a prospective, multicenter study. Plast Reconstr Surg 2003;111:1060-1068.
36. Metcalfe KA, Semple J, Quan ML, et al. Changes in psychosocial functioning 1 year after mastectomy alone, delayed breast reconstruction, or immediate breast reconstruction. Ann Surg Oncol 2012;19:233-241.
37. Hartmann LC, Sellers TA, Schaid DJ, et al. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 2001;93:1633-1637.
38. Sherry RM. Cancer prevention: role of surgery in cancer prevention. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds). Cancer: Principles and Practice of Oncology, 6th edn. Lippincott Williams and Wilkins: Philadelphia, PA, 2001.
39. Doheny K. Most women don't understand their breast cancer risk: survey. http://healthyliving.msn.com/diseases/breast-cancer/most-women-dontunderstand- their-breast-cancer-risk-survey.Accessed4September2013.
40. Ogata Jones K, Denham BE, Springston JK. Effects of mass and interpersonal communication on breast cancer screening: advancing agenda-setting theory in health contexts. J Appl Commun Res 2006;34:94-113.